SGEN Seagen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGEN

Price (delayed)

$178.88

Market cap

$32.93B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.77

Enterprise value

$32.72B

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is ...

Highlights
SGEN's debt is down by 8% year-on-year and by 5% since the previous quarter
SGEN's gross profit is down by 34% year-on-year but it is up by 6% since the previous quarter
The company's revenue fell by 27% YoY but it rose by 6% QoQ
The EPS has shrunk by 199% YoY
The quick ratio has decreased by 40% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: IMGN BIIB CLDX SPPI

Key stats

What are the main financial stats of SGEN
Market
Shares outstanding
184.08M
Market cap
$32.93B
Enterprise value
$32.72B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.95
Price to sales (P/S)
19.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.61
Earnings
Revenue
$1.67B
EBIT
-$689.53M
EBITDA
-$609.49M
Free cash flow
-$652.71M
Per share
EPS
-$3.77
Free cash flow per share
-$3.55
Book value per share
$16.33
Revenue per share
$9.09
TBVPS
$16.81
Balance sheet
Total assets
$3.62B
Total liabilities
$618.23M
Debt
$53.55M
Equity
$3B
Working capital
$2.24B
Liquidity
Debt to equity
0.02
Current ratio
5.22
Quick ratio
4.43
Net debt/EBITDA
0.34
Margins
EBITDA margin
-36.5%
Gross margin
79.9%
Net margin
-41.3%
Operating margin
-41.5%
Efficiency
Return on assets
-18.1%
Return on equity
-21.9%
Return on invested capital
-29.6%
Return on capital employed
-22.3%
Return on sales
-41.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SGEN stock price

How has the Seagen stock price performed over time
Intraday
0.23%
1 week
5.43%
1 month
26.52%
1 year
12.79%
YTD
15.71%
QTD
24.18%

Financial performance

How have Seagen's revenue and profit performed over time
Revenue
$1.67B
Gross profit
$1.33B
Operating income
-$692.69M
Net income
-$689.55M
Gross margin
79.9%
Net margin
-41.3%
SGEN's gross profit is down by 34% year-on-year but it is up by 6% since the previous quarter
The company's revenue fell by 27% YoY but it rose by 6% QoQ
The gross margin has decreased by 10% YoY
The company's operating margin rose by 4.2% QoQ

Growth

What is Seagen's growth rate over time

Valuation

What is Seagen stock price valuation
P/E
N/A
P/B
10.95
P/S
19.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.61
The EPS has shrunk by 199% YoY
The price to book (P/B) is 20% more than the last 4 quarters average of 9.1 and 10% more than the 5-year quarterly average of 9.9
SGEN's equity is down by 12% YoY and by 2.2% from the previous quarter
The company's revenue fell by 27% YoY but it rose by 6% QoQ
The P/S is 24% above the last 4 quarters average of 15.9 and 14% above the 5-year quarterly average of 17.2

Efficiency

How efficient is Seagen business performance
Seagen's return on equity has shrunk by 191% YoY and by 6% QoQ
The return on assets has dropped by 190% year-on-year and by 4.6% since the previous quarter
The ROIC has plunged by 184% YoY and by 6% from the previous quarter
The ROS has increased by 3.7% QoQ

Dividends

What is SGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGEN.

Financial health

How did Seagen financials performed over time
The quick ratio has decreased by 40% YoY
Seagen's current ratio has decreased by 35% YoY but it has increased by 3.6% from the previous quarter
SGEN's debt is 98% smaller than its equity
SGEN's equity is down by 12% YoY and by 2.2% from the previous quarter
SGEN's debt is down by 8% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.